Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma for Non-Tuberculous Mycobacterial Infections
NCT00001318Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 1992
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon gamma-1b in nontuberculous mycobacterial infection (NTM), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Clinical condition at 1 year and Immune function at 1 year. Started Aug 1992; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
nontuberculous mycobacterial infection (NTM)
Beyond the preview
Go deeper on NCT00001318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001318.